Home|Journals|Articles by Year|Audio Abstracts RSS - TOC

SRP. 2020; 11(4): 577-579

The Role Folic Acid and Zinc Sulphate in the Treatment of Idiopathic Infertility (A Local Study)

Waleed Nassar Jaffal, Ehab Jasim Mohammad, Duraid Taha Abdulkareem.


Objective: to evaluate the affect zinc sulphate and folic acid handling on the seminal fluid factor in patients with idiopathic male infertility.
Patients and methods: From February 2013 to February 2020, 700 patients with idiopathic primary infertility, presented to Al Yarmouk teaching hospital and Al Ramadi teaching hospital in addition to 3 private clinics were enrolled in this prospective study, their age ranged from 17 to 56 years, Semen evaluation done for all patients at the start of study (baseline) and after three months of treatment. The patients received folic acid 5 mg and zinc sulphate 60 mg prepared in special capsules once daily for 3 months.
Results: Seven hundreds patients completed the treatment period for 3 months. The age of patients raged from 17 to 56 years, there was statistically significant difference in the sperm concentration after treatment compared to baseline and also statistically significant difference in the perm motility after 3 months treatment period (p value < 0.05).The increment in the percentage of normal morphology was statistically non-significant, and also the slight increase in the seminal fluid volume was non-significant (p value > 0.05).
Conclusion: Handling of idiopathic male infertility with combination of zinc sulphate and folic acid was safe and effective in improving seminal fluid parameters.

Key words: folate, zinc, idiopathic, infertility

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.